Hypoglycemia in Hospice Patients With Type 2 Diabetes in a National Sample of Nursing Homes

Laura A Petrillo; Siqi Gan; Bocheng Jing; Sean Lang-Brown; W John Boscardin; Sei J Lee

doi:10.1001/jamainternmed.2017.7744

Hypoglycemia in Hospice Patients With Type 2 Diabetes in a National Sample of Nursing Homes

JAMA Intern Med. 2018 May 1;178(5):713-715. doi: 10.1001/jamainternmed.2017.7744.

Authors

Laura A Petrillo^{1

2}, Siqi Gan³, Bocheng Jing^{2

4}, Sean Lang-Brown^{2

4}, W John Boscardin^{2

4}, Sei J Lee^{2

4}

Affiliations

¹ Department of Medicine, Massachusetts General Hospital, Boston.
² Department of Medicine, University of California, San Francisco, San Francisco.
³ Healthcare Department, Philips Research China. Shanghai, China.
⁴ San Francisco Veterans Affairs Medical Center, San Francisco, California.

Abstract

This retrospective cohort study examines whether patients with type 2 diabetes on hospice are assessed for dysglycemia, receive insulin or oral hypoglycemic medications, or experience hypoglycemia and hyperglycemia in the nursing home setting.

MeSH terms

Aged
Diabetes Mellitus, Type 2 / epidemiology*
Female
Hospice Care*
Humans
Hypoglycemia / epidemiology*
Incidence
Male
Nursing Homes*
Retrospective Studies
United States / epidemiology
Veterans / statistics & numerical data*

Grants and funding

P30 AG044281/AG/NIA NIH HHS/United States